USPTO serial 79393328
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Catherine F. Hoffman
Catherine F. Hoffman Baker, Donelson, Bearman, Caldwell, & Be200 East Broward Blvd, Suite 2000Ft. Lauderdale, FL 33301United States| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Apparatus for recording, transmitting, reproducing sound or images corresponding to a biometric signal; measuring and testing machines and instruments for measuring inertia, acceleration, motion, time, images, sounds, location, proximity, pressure, screen touches, heading and orientation, other than for medical purposes; measuring and testing machines and instruments for measuring human activities, movement, body position, human body movement, fatigability, motor function, gait, gait speed, step symmetry, rigidity, cognition, memory, executive functioning, vision, visual acuity, contrast sensitivity, eye movements, mouth movements, voice, vocalizations, speech, enunciation, diction, dexterity, typing speed, pronation, supination and balance, other than for medical purposes; measuring and testing machines and instruments for measuring human activities, medical signs and biometric signals associated with movement and cognitive disabilities, motor function disorders and cognitive diseases, dementia, Multiple Sclerosis, Parkinson's disease, Alzheimer's disease, other neurodegenerative diseases, rheumatologic disorders and metabolic disorders, other than for medical purposes; measuring and testing machines and instruments, namely, wearable monitors used to measure human activities, medical signs and biometric signals for scientific or medical research use; measuring and testing machines and instruments, namely, portable monitors used to measure biometric data for use in scientific studies; measuring and testing machines and instruments, namely, portable monitors used to measure biometric data for use in clinical trials for scientific or research purposes; measuring and testing machines and instruments being electronic devices for scientific studies comprised of sensors for gathering biometric signals and apparatus for measuring relative biometric signals; measuring and testing machines and instruments being electronic devices for clinical trials comprised of sensors for gathering biometric signals and apparatus for measuring relative biometric signals, for scientific or research purposes; measuring and testing machines and instruments, namely, sensors for scientific and medical research use to be worn by a human to gather human biometric data and also including measurement apparatus sold as a unit; measuring and testing machines and instruments, namely, sensors for scientific and medical research use to gather human biometric data; measuring and testing machines and instruments, namely, testing and measuring equipment for use in testing the safety and efficacy of pharmaceutical compounds; measuring and testing machines and instruments for measuring human activities, medical signs and biometric signals associated with movement and cognitive disabilities, motor function disorders and cognitive diseases, dementia, Multiple Sclerosis, Parkinson's disease, Alzheimer's disease, neurodegenerative diseases, rheumatologic disorders and metabolic disorders, for scientific or research purposes, not for medical purposes; measuring and testing machines and instruments for measuring human activities, medical signs and biometric signals being electronic devices comprised of sensors for gathering biometric signals and apparatus for measuring relative biometric signals, for scientific or research purposes, not for medical purposes; measuring and testing machines and instruments for measuring human activities, medical signs and biometric signals, namely, sensors for measuring human activities, medical signs and biometric signals associated with neurological disorders, motor function disorders and cognitive diseases, dementia, Multiple Sclerosis, Parkinson's disease, Alzheimer's disease, neurodegenerative diseases, rheumatologic disorders and metabolic disorders, for scientific or research purposes, not for medical purposes; measuring and testing machines and instruments for measuring human activities, medical signs and biometric signals, namely,, namely, electrodes not for medical purposes; measuring and testing machines and instruments for measuring human activities, medical signs and biometric signals, namely,, namely, electrodes for the input, output, transmission, storage, and processing of data, in particular scientific and medical data not for medical purposes; sensors for measuring inertia, acceleration, motion, time, images, sounds, location, proximity, pressure, screen touches, heading and orientation, other than for medical use; sensors for measuring human activities, medical signs, biometric signals, movement, body position, human body movement, fatigability, motor function, gait, gait speed, step symmetry, rigidity, cognition, memory, executive functioning, vision, visual acuity, contrast sensitivity, eye movements, mouth movements, voice, vocalizations, speech, enunciation, diction, dexterity, typing speed, pronation, supination, and balance, scientific studies other than for medical use; sensors for measuring human activities, medical signs, biometric signals, movement, body position, human body movement, fatigability, motor function, gait, gait speed, step symmetry, rigidity, cognition, memory, executive functioning, vision, visual acuity, contrast sensitivity, eye movements, mouth movements, voice, vocalizations, speech, enunciation, diction, dexterity, typing speed, pronation, supination, and balance, for scientific or research purposes, other than for medical use; sensors for measuring human activities, medical signs and biometric signals associated with neurological disorders, motor function disorders and cognitive diseases, dementia, Multiple Sclerosis, Parkinson's disease, Alzheimer's disease, other neurodegenerative diseases, rheumatologic disorders and metabolic disorders, other than for medical use; sensors for measuring human activities, medical signs and biometric signals associated with neurological disorders, motor function disorders and cognitive diseases, dementia, Multiple Sclerosis, Parkinson's disease, Alzheimer's disease, neurodegenerative diseases, rheumatologic disorders and metabolic disorders, for scientific or research purposes other than for medical use; sensors for measuring human biometric data, other than for medical use; instruments and devices being cameras, touch screens, microphones, accelerometers, GPS receivers, gyroscopes, magnetometers, signal processors, data processors, pressure sensors, and electrodes, for the input, output, transmission, storage, and processing of data, in particular scientific and medical data; Downloadable and recorded software for monitoring, recording and analyzing a biometric signal, other than for medical use; Downloadable and recorded software for monitoring, recording and analyzing a biometric signal; Downloadable and recorded software for monitoring, recording and analyzing a biometric signal in the field of physical exercise and sports; Downloadable and recorded software for monitoring, recording and analyzing movement, balance, dexterity and vision; downloadable computer software applications for data collection, data storage and data analysis for clinical trials, preclinical, and clinical and medical research; downloadable computer software applications for managing clinical trials, preclinical, and clinical and medical research; downloadable computer software applications for data processing for use in connection with clinical trials, preclinical, and clinical and medical research; downloadable computer software applications for data processing relating to clinical trials and, preclinical, clinical and medical research; downloadable computer software applications for use in managing data and information in the field of medical quality improvement initiatives, clinical trials, preclinical, and clinical and medical research; downloadable computer software applications for capturing, monitoring, tracking, analyzing and reporting measurements of human activities, medical signs, biometric signals, movement, body position, human body movement, fatigability, motor function, gait, gait speed, step symmetry, rigidity, cognition, memory, executive functioning, vision, visual acuity, contrast sensitivity, eye movements, mouth movements, voice, vocalizations, speech, enunciation, diction, dexterity, typing speed, pronation, supination and balance; downloadable computer software applications for measuring human brain health; downloadable computer software applications for measuring cognition; downloadable computer Software applications in the nature of smartphone-based cognitive games for estimating volume of key brain structures for cognitive function; downloadable computer Software applications in the nature of smartphone-based cognitive games for measuring mental attention, processing speed, mental flexibility, information processing, executive functions, language, visuospatial abilities, social cognition, working memory and, short-term and long-term memory; downloadable Software as a Medical Device (SaMD) for use as a medical instrument for testing movement, balance, dexterity, cognition, vision, motor function; downloadable Software as a Medical Device (SaMD) for testing movement, balance, dexterity, cognition, vision, motor function; downloadable Software as a Medical Device (SaMD) for assessing, tracking and monitoring neurological disorders, motor function disorders and cognitive diseases, dementia, Multiple Sclerosis, Parkinson's disease, Alzheimer's disease, other neurodegenerative diseases, rheumatologic disorders and metabolic disorders; downloadable Software as a Medical Device (SaMD) for diagnosing neurological disorders, motor function disorders and cognitive diseases, dementia, Multiple Sclerosis, Parkinson's disease, Alzheimer's disease, rheumatologic disorders and metabolic disorders; downloadable Software as a Medical Device (SaMD) for testing for biomarkers associated with neurological disorders, motor function disorders and cognitive diseases, dementia, multiple sclerosis, Parkinson's disease, Alzheimer's disease, other neurodegenerative diseases, rheumatologic disorders and metabolic disorders; downloadable Software as a Medical Device (SaMD) for measuring human brain health; downloadable Software as a Medical Device (SaMD) for measuring human brain health, namely, downloadable Software as a Medical Device (SaMD) for assessing, tracking and monitoring neurodegenerative diseases; downloadable Software as a Medical Device (SaMD) for measuring human brain health, namely, downloadable Software as a Medical Device (SaMD) for testing for biomarkers associated with neurodegenerative diseases; downloadable Software as a Medical Device (SaMD) for measuring cognition; downloadable Software as a Medical Device (SaMD) for measuring cognition, namely, downloadable Software as a Medical Device (SaMD) for assessing, tracking and monitoring neurodegenerative diseases; downloadable Software as a Medical Device (SaMD) for measuring cognition, namely, downloadable Software as a Medical Device (SaMD) for testing for biomarkers associated with neurodegenerative diseases; downloadable computer software applications for acquiring, tracking and processing a biometric signal, in the field of fitness and physical exercise; Downloadable computer application software for smartphones and mobile devices for capturing, monitoring, tracking, analyzing and reporting measurements of human activities, medical signs, biometric signals, movement, body position, human body movement, fatigability, motor function, gait, gait speed, step symmetry, rigidity, cognition, memory, executive functioning, vision, visual acuity, contrast sensitivity, eye movements, mouth movements, voice, vocalizations, enunciation, diction, dexterity, typing speed, pronation, supination and balance in the fields of physical fitness and exercise; wearable activity trackers; biochips for research or scientific purposes; biometric readers; motion sensors; vision sensors; wearable computers in the nature of smartglasses; wearable computers in the nature of smartwatches; wearable computers in the nature of portable electronic devices with sensors for registering the physical movements, general behavior and cognition of a human clinical trial subject wearing or carrying the device; wearable computers in the nature of activity trackers to collect information of human activities and medical signs; wearable computers in the nature of activity and medical sign trackers for detecting and treating disease being neurological disorders, motor function disorders and cognitive diseases, dementia, multiple sclerosis, Parkinson's disease, Alzheimer's disease, other neurodegenerative diseases, rheumatologic disorders and metabolic disorders; wearable computers in the nature of activity and medical sign trackers for detecting and treating disease, namely, wearable measuring and testing machines and instruments for measuring human activities, medical signs and biometric signals associated with movement and cognitive disabilities, motor function disorders and cognitive diseases, dementia, Multiple Sclerosis, Parkinson's disease, Alzheimer's disease, neurodegenerative diseases, rheumatologic disorders and metabolic disorders, other than for medical purposes; wearable computers in the nature of activity and medical sign trackers for detecting and treating disease, namely, wearable sensors for measuring human activities, medical signs and biometric signals associated with neurological disorders, motor function disorders and cognitive diseases, dementia, Multiple Sclerosis, Parkinson's disease, Alzheimer's disease, neurodegenerative diseases, rheumatologic disorders and metabolic disorders, other than for medical use; wearable computers in the nature of activity and medical sign trackers for detecting and treating disease, namely, wearable electrodes; wearable computers in the nature of activity and medical sign trackers for detecting and treating disease, namely, electrodes, for the input, output, transmission, storage, and processing of data, in particular scientific and medical data; wearable computers in the nature of activity and medical sign trackers for detecting and treating disease, namely, wearable instruments and devices being cameras, touch screens, microphones, accelerometers, GPS receivers, gyroscopes, magnetometers, signal processors, data processors, pressure sensors, and electrodes, for the input, output, transmission, storage, and processing of data, in particular scientific and medical data; wearable computers in the nature of activity and medical sign trackers for detecting and treating disease; wearable computers in the nature of computer hardware and recorded software sold as a unit for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data | ACTIVE | — |
| 042 | Scientific and technological services, namely, analysis of measurements of human activities, medical signs, biometric signals, movement, body position, human body movement, fatigability, motor function, gait, gait speed, step symmetry, rigidity, cognition, memory, executive functioning, vision, visual acuity, contrast sensitivity, eye movements, mouth movements, voice, vocalizations, speech, enunciation, diction, dexterity, typing speed, pronation, supination and balance for scientific research purposes in the field of health, fitness, physical activity, and wellness; Scientific and technological services, namely, scientific research for medical purposes in the area of neurodegenerative diseases in the field of health, fitness, physical activity, and wellness; Scientific and technological services, namely, research and design relating thereto in the field of health, fitness, physical activity, and wellness; industrial research and research services in the field of clinical and therapeutic monitoring; designing and developing computer hardware and software; designing and developing non-downloadable software for monitoring; physical fitness, health and wellness goals and statistics; designing and developing non-downloadable software for monitoring physical fitness, health and wellness goals and statistics; designing and developing non-downloadable software for displaying, aggregating, analyzing and organizing data and information in the fields of health, wellness, physical fitness and activity and performance; Medical and scientific research, namely, conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others; providing online, non-downloadable computer software platforms for capturing, storing, registering, tracking, analyzing and reporting measurements of human activities, medical signs, biometric signals, movement, body position, human body movement, fatigability, motor function, gait, gait speed, step symmetry, rigidity, cognition, memory, executive functioning, vision, visual acuity, contrast sensitivity, eye movements, mouth movements, voice, vocalizations, speech, enunciation, diction, dexterity, typing speed, pronation, supination and balance; providing online, non-downloadable computer software platforms for storing, registering, tracking, analyzing and reporting sensor-derived data; providing online, non-downloadable computer software platforms for use in database and data management in the fields of neurology and motor function; providing online, non-downloadable computer software platforms for administration and monitoring of users for use in connection with clinical trials, clinical practice and medical research; providing online, non-downloadable computer software platforms for electronically managing computers worn by participants for use in connection with clinical trials, clinical practice and medical research; providing online, non-downloadable computer software platforms for electronically monitoring computers worn by participants for use in connection with clinical trials, clinical practice and medical research; providing online, non-downloadable computer software platforms for managing, controlling and monitoring of wearable computers, measuring and testing machines and instruments, sensors, wearable activity trackers, biochips, biometric readers, cameras, touch screens, microphones, accelerometers, GPS receivers, gyroscopes, magnetometers, signal processors, data processors, pressure sensors and electrodes for use in connection with clinical trials, clinical practice and medical research; providing online, non-downloadable computer software platforms for managing and monitoring of user data associated with wearable computers, measuring and testing machines and instruments, sensors, wearable activity trackers, biochips, biometric readers, cameras, touch screens, microphones, accelerometers, GPS receivers, gyroscopes, magnetometers, signal processors, data processors, pressure sensors and electrodes for use in connection with clinical trials, clinical practice and medical research; providing online, non-downloadable computer software platforms for managing clinical trials; providing online, non-downloadable computer software platforms for managing collection of human subject data in clinical trials; providing online, non-downloadable computer software platforms for monitoring, tracking, analyzing and reporting changes in human subject health in clinical trials; providing online, non-downloadable computer software platforms for providing medical and scientific information on clinical trials; providing online, non-downloadable computer software platforms for providing medical and scientific research information about the results of clinical trials for pharmaceutical products; providing online, non-downloadable computer software platforms for assessing neurodegenerative disorders; providing online, non-downloadable computer software platforms for assessing motor function disorders and cognitive diseases; providing online, non-downloadable computer software platforms for use in characterizing symptoms associated with neurodegenerative disease, rheumatologic disorders and metabolic disorders; development of computer platforms; Platform as a services (PAAS) services featuring computer software platforms for storing, registering, tracking, analyzing and reporting measurements of human activities, medical signs, biometric signals, movement, body position, human body movement, fatigability, motor function, gait, gait speed, step symmetry, rigidity, cognition, memory, executive functioning, vision, visual acuity, contrast sensitivity, eye movements, mouth movements, voice, vocalizations, speech, enunciation, diction, dexterity, typing speed, pronation, supination and balance; Platform as a services (PAAS) services featuring computer software platforms for storing, registering, tracking, analyzing and reporting sensor-derived data; Platform as a services (PAAS) services featuring computer software platforms for use in database and data management in the fields of neurology and motor function; Platform as a services (PAAS) services featuring computer software platforms for managing collection of patient data; Platform as a services (PAAS) services featuring computer software platforms for storing, registering, tracking, analyzing and reporting patient motor function measurements in the field of the neurology; Platform as a services (PAAS) services featuring computer software platforms for use in database management in the field of the neurology to monitor, track and improve patient motor function; Platform as a services (PAAS) services featuring computer software platforms for providing instructions for patients requiring neurological treatment who are suffering from medical issues related to motor functions; Platform as a services (PAAS) services featuring computer software platforms for providing instructions to patients requiring neurological treatment who are suffering from medical issues related to motor functions; Platform as a services (PAAS) services featuring computer software platforms for assessing neurodegenerative disorders; Platform as a services (PAAS) services featuring computer software platforms for assessing motor function disorders and cognitive diseases; Platform as a services (PAAS) services featuring computer software platforms for monitoring, tracking, analyzing and reporting changes in patient health; programming of software for Internet platforms for others; Application service provider featuring application programing interface (API) software for enabling data retrieval, user data upload, access, management, monitoring and analysis; Providing temporary use of non-downloadable computer software for the design, creation and analysis of data, metrics and reports in the fields of health, fitness, physical activity, and well-being; Providing temporary use of non-downloadable computer software for the design, creation and analysis of data, metrics and reports in the fields of health associated with neurological disorders, motor function disorders and cognitive diseases, dementia, Multiple Sclerosis, Parkinson's disease, Alzheimer's disease, rheumatologic disorders and metabolic disorders, based on the measurements of human activities, medical signs, biometric signals, movement, body position, human body movement, fatigability, motor function, gait, gait speed, step symmetry, rigidity, cognition, memory, executive functioning, vision, visual acuity, contrast sensitivity, eye movements, mouth movements, voice, vocalizations, speech, enunciation, diction, dexterity, typing speed, pronation, supination and balance; development and maintenance of software; software development and maintenance in the field of health, fitness and physical exercise; software development and maintenance in the field of health associated with neurological disorders, motor function disorders and cognitive diseases, dementia, Multiple Sclerosis, Parkinson's disease, Alzheimer's disease, rheumatologic disorders and metabolic disorders; development of data storage systems, particularly in the field of health, fitness and physical exercise; design and development of systems for data input, extraction, processing, display and storage; design and development of data entry, retrieval, processing, display and storage systems in the field of health, fitness and physical exercise; research and development services in the field of technology for measuring, monitoring, controlling and analyzing data in the field of biometrics, in particular in the field of digital biomarkers focused on the fields of movement, balance, dexterity and vision | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 12, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 18, 2026 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 12, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 12, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 24, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 24, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 18, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 12, 2026 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 4, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 3, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 25, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 25, 2026 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 3, 2026 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 22, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 21, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 20, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 13, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 13, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 13, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 13, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 13, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 5, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 5, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 5, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 14, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 14, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 14, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 3, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 3, 2025 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Sep 10, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 10, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 9, 2025 | RFNP | REFUSAL PROCESSED BY IB | — |
| Apr 14, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 17, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 17, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 17, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 25, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 9, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 19, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 18, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 9, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 8, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 22, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 23, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 18, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 16, 2024 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 11, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |